Could administration of bacille Calmette-Guérin vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated?
- 1 June 2002
- journal article
- review article
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 13 (3) , 172-176
- https://doi.org/10.1034/j.1399-3038.2002.01048.x
Abstract
Asthma and allergic diseases are disorders with a predominant Th2 immune response and there is some evidence of an inverse correlation between incidence of tuberculosis and prevalence of allergic diseases. Skewing the immune response towards a Th1 phenotype has been shown to suppress allergic inflammation. One of the ways this could be achieved is by administration of BCG vaccination early in life. Unfortunately, studies examining the protective role of BCG vaccination early in life against development of allergic diseases have shown some conflicting results and this article critically discusses the pitfalls in the currently available data. We propose that well controlled double blind placebo-controlled multi-centre study is carried out to address this important question and if this study shows a favourable outcome simple measures such as offering BCG vaccination early in life could help reduce prevalence of allergic diseases.Keywords
This publication has 30 references indexed in Scilit:
- Interleukin-9 Upregulates Mucus Expression in the AirwaysAmerican Journal of Respiratory Cell and Molecular Biology, 2000
- Interleukin-9 receptor expression in asthmatic airways In vivo.Lung, 2000
- IL-9 and its receptor in allergic and nonallergic lung disease: Increased expression in asthmaJournal of Allergy and Clinical Immunology, 2000
- Long-Term Clinical Efficacy of Grass-Pollen ImmunotherapyNew England Journal of Medicine, 1999
- Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin productionJournal of Clinical Investigation, 1999
- Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAACThe Lancet, 1998
- Interleukin 9: A candidate gene for asthmaProceedings of the National Academy of Sciences, 1997
- Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.Journal of Clinical Investigation, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional PropertiesAnnual Review of Immunology, 1989